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Myostatin, a negative regulator of skeletal muscle mass in animals, has been shown
to play a role in determining muscular hypertrophy in several livestock species, and a
high degree of polymorphism has been previously reported for this gene in humans
and cattle. In this study, we provide a characterization of the myostatin gene in the
dromedary (Camelus dromedarius) at the genomic, transcript and protein level. The
gene was found to share high structural and sequence similarity with other mammals,
notably Old World camelids. 3D modeling highlighted several non-conservative SNP
variants compared to the bovine, as well as putative functional variants involved in
the stability of the myostatin dimer. NGS data for nine dromedaries from various
countries revealed 66 novel SNPs, all of them falling either upstream or downstream the
coding region. The analysis also confirmed the presence of three previously described
SNPs in intron 1, predicted here to alter both splicing and transcription factor binding
sites (TFBS), thus possibly impacting myostatin processing and/or regulation. Several
putative TFBS were identified in the myostatin upstream region, some of them belonging
to the myogenic regulatory factor family. Patterns of SNP distribution across countries,
as suggested by Bayesian clustering of the nine dromedaries using the 69 SNPs,
pointed to weak geographic differentiation, in line with known recurrent gene flow at
ancient trading centers along caravan routes. Myostatin expression was investigated
in a set of 8 skeletal muscles, both at transcript and protein level, via Digital Droplet
PCR and Western Blotting, respectively. No significant differences were observed at
the transcript level, while, at the protein level, the only significant differences concerned
the promyostatin dimer (75 kDa), in four pair-wise comparisons, all involving the tensor
fasciae latae muscle. Beside the mentioned band at 75 kDa, additional bands were
observed at around 40 and 25 kDa, corresponding to the promyostatin monomer and
the active C-terminal myostatin dimer, respectively. Their weaker intensity suggests that
the unprocessed myostatin dimers could act as important reservoirs of slowly available
myostatin forms. Under this assumption, the sequential cleavage steps may contribute
additional layers of control within an already complex regulatory framework.
Keywords: Camelus dromedarius, myostatin, skeletal muscle, Single Nucleotide Polymorphisms, Next
Generation Sequencing, Digital Droplet PCR, Western Blot, 3D protein comparative modeling
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INTRODUCTION
Myostatin (alias growth and differentiation factor-8, GDF8), a
member of the transforming growth factor-β (TGF-β) super-
family, is a negative regulator of skeletal muscle mass in animals
during development and growth. It is exclusively expressed in
skeletal muscle during embryogenesis, while in adults is also
detected, at a much lower level, in other tissues (e.g., heart,
adipose tissue, mammary gland) (McPherron et al., 1997; Ji et al.,
1998; Sharma et al., 1999; Morissette et al., 2006; Shyu et al., 2006;
Allen et al., 2008). Expression in these tissues can be upregulated
under pathological conditions, such as myocardial infarction
(Sharma et al., 1999), obesity (Allen et al., 2008) or experimentally
induced skeletal muscle atrophy (Rodriguez et al., 2014), while
it can be down regulated during chronic exercise (Carlson et al.,
1999; Reardon et al., 2001; Kim et al., 2005; Matsakas et al., 2006;
Allen et al., 2009; Gustafsson et al., 2010).
Like other TGF-β super-family members, myostatin is
synthesized as a precursor protein (375 amino acids), referred
to as pre-promyostatin. After translocation to the endoplasmic
reticulum, it goes through a first cleavage to remove a 24-amino
acid signal peptide and it forms a disulfide-linked homodimer
(promyostatin dimer). Within the Golgi, the promyostatin dimer
may be further cleaved by the furin family of protein convertases
to generate two NH2-terminal (27.7 kDa, each) and two disulfide-
linked COOH-terminal fragments (12.4 kDa, each) (Lee and
McPherron, 2001; Thies et al., 2001). The two NH2-terminal
fragments (also referred to as pro-domains) may complex with
the COOH-terminal dimer (also referred to as active myostatin)
via a non-covalent bound that maintains myostatin in a latent
state by rendering it unable to engage its receptors (Wolfman
et al., 2003; Jiang et al., 2004). The “latent myostatin complex”
(Lee and McPherron, 2001; Thies et al., 2001) may be secreted
in the extracellular space, though it has been shown that, in
skeletal myocytes, myostatin is mainly secreted as uncleaved
promyostatin (Anderson et al., 2008; Pirruccello-Straub et al.,
2018). In the extracellular space, the action of furin protein
convertase and metalloproteinases (like BMP-1, TLL-1, and TLL-
2) may finally convert the uncleaved promyostatin and the
latent complex, respectively, into the active form of myostatin
(Lakshman et al., 2009). Notwithstanding, in serum, myostatin
has been shown to exist mainly as a latent complex (Hill et al.,
2002; Zimmers et al., 2002; Lee, 2010). The active myostatin
present in plasma circulates bound to several proteins (Miura
et al., 2006; Cash et al., 2009; Walker et al., 2015), including
follistatin, FSTL3, GASP1, GASP2 and decorin, that prevent
it binding to the receptor and activating signaling (Hill et al.,
2002, 2003; Lee, 2008; Cotton et al., 2018). Composite pools
of myostatin are hence available at the various compartments,
suggesting that extracellular processing of the protein may be
a key regulatory step for its signaling (Anderson et al., 2008).
The presence, at various extents, of the myostatin active form
in the extracellular space and in the serum is consistent with
the postulated autocrine, paracrine (Gao et al., 2013), and/or
endocrine manner of function (Zimmers et al., 2002).
Upon binding to the target cell, myostatin induces the
formation of a heterotetrameric complex made of two activin
responsive type II receptors (ActIIRA or, preferentially, ActIIRB)
and two type I receptors, either activin (ALK4) or TGF-β (ALK5)
(Lee and McPherron, 2001; Rebbapragada et al., 2003). Signaling
is hence initiated by phosphorylation of SMAD2 or SMAD3,
operated by the type I receptors, followed by translocation
of SMADs to the nucleus for modulation of gene expression
(Huang et al., 2011). In particular, in skeletal muscle, myostatin
is known to block the transcription of genes responsible for
the myogenesis, among which MyoD, a transcriptional factor
that is involved in skeletal muscle development and repair
(Megeney et al., 1996; Cornelison et al., 2000; Guttridge et al.,
2000; Montarras et al., 2000). Beside the above mentioned
canonical pathway, two other pathways have been highlighted,
involving MAPK activation or inhibition of Akt signaling
(Elkina et al., 2011).
Myostatin genomic organization was first provided for the
murine species by McPherron et al. (1997) who also reported on
the highly conserved nature of the myostatin transcript across
several species. The myostatin gene (MSTN) comprises three
exons and two introns. The nucleotide sequence coding for the
active form of myostatin (109 a.a) is located in the 3′ terminal
of the third exon (Gonzalez-Cadavid et al., 1998). Effects of
abolishing myostatin function were first explored by McPherron
et al. (1997) in mutant mice where the entire mature C-terminal
region was deleted, showing a two- to three-fold increase in
skeletal muscle mass in mutant compared to wild-type animals.
Mutations at the myostatin gene, responsible for a significantly
increased skeletal muscle mass, were also shown to naturally
occur in several livestock species, like cattle, sheep, pigs, dogs,
horses, rabbit, poultry (for a review, see Aiello et al., 2018),
and human (Schuelke et al., 2004). In particular, the high level
of polymorphism previously described for the myostatin gene
in humans (Ferrell et al., 1999) was confirmed in cattle in a
survey of 678 animals from 28 European breeds by using Single
Strand Conformation Polymorphism (SSCP) analysis, followed
by Sanger sequencing of the PCR re-amplified SSCP bands
(Dunner et al., 2003). A total of 10 silent, 3 missense and 6
disruptive mutations were detected in the above study, giving
origin to 20 distinct haplotypes whose sequence variation and
breed distribution patterns supported the hypothesis that origin
of muscular hypertrophy (also known in cattle as “double muscle”
phenotype) was the result of both (i) European dispersal of the
common variant nt821(del11) and (ii) arising and maintaining of
various (mostly disruptive) mutations in single breeds.
Old World camels include both wild (Camelus ferus)
and domestic (Camelus dromedarius and Camelus bactrianus)
species. Despite differences in muscularity can be observed
among distinct populations and/or individuals, these are not
dramatic as those observed in other livestock species and no
evident “double muscle” phenotype has been described so far (B.
Faye, personal communication). The myostatin gene has been
previously characterized in various dromedary populations from
Pakistan and India, although only 256 bp of exon 1 and 375 bp of
exon 2, respectively, were considered in the analyses (Shah et al.,
2006; Agrawal et al., 2017). A more comprehensive sequence
polymorphism analysis of the myostatin gene was performed in
our laboratories, where more than 3.6 kb of genomic sequence,
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including the three exons, small part of the introns and part of the
3′ and 5′ ends, was sequenced in a total of 22 dromedaries from
three different Northern African geographic regions (Muzzachi
et al., 2015). In this study, to further expand the knowledge
base about myostatin, we followed up by (i) characterizing
the gene structure (transcriptional initiation/termination sites;
exon/intron boundaries), (ii) analyzing polymorphism of the
complete genomic sequence and of the partial cDNA in a set of
animals from various sampling sites, (iii) investigating expression
patterns at both the transcript and the protein level in different
skeletal muscles.
MATERIALS AND METHODS
Characterization of the Full-Length
Myostatin cDNA
RNA Isolation From Skeletal Muscles
Skeletal muscles were sampled at slaughterhouses from seven
different animals (Sudan, 3; Egypt, 2; Mauritania, 2). For each
animal, a small sample of frozen muscle tissue (100 mg),
previously stored in tubes containing RNAlater (QIAGEN),
was finely chopped by using a sharp scalpel in 2 ml
RLT buffer (RNeasy Midi Kit, QIAGEN) supplemented with
β-mercaptoethanol following the manufacturer’s instructions.
The sample was then homogenized using the T 10 basic Ultra-
Turrax homogenizer (IKA). After homogenization, the sample
was added with 4 ml of RNase-/DNase-free water plus 65 µl
of Proteinase K (SIGMA, ≥0.6 Units/µl). After an incubation
step at 55◦C for 20 min, samples were processed following
manufacturer’s instruction.
Myostatin Transcription Initiation and Termination
Sites
Transcription initiation and termination sites were
identified using the RACE (Rapid amplification of cDNA
ends) PCR approach implemented in the SMARTer
RACE cDNA Amplification Kit (CloneTech) following
manufacturer’s instructions.
For the 5′RACE-PCR, the following primers were used:
• 1st reaction: 5′ATCCTCAGTAAACTTCGCCTGGAAAC
AGCT3′
• 2nd reaction: 5′GGCTGTGTAATGCATGTATGTGGAGA
CAAA3′
For the 3′RACE-PCR, the following primers were used:
• 1st reaction: 5′TGTGCACCAAGCAAACCCCAGAGGTT
CGGC3′
• 2nd reaction: 5′CCTGCTGTACTCCCACAAAGATGTCT
CCAA3′
After separation on a 2% agarose gel, PCR products were
excised from the gel, purified using the QIAquick Gel Extraction
Kit (QIAGEN) and sequenced using the following primers:
5′RACE: 5′TTTGTCTCCACATACATGCATTACACAGCC3′
3′RACE: 5′CCTGCTGTACTCCCACAAAGATGTCTCCAA3′
RNA Retro-Transcription
After quality control using a NanoDrop 2000C
spectrophotometer (Thermo Fisher Scientific), 50 µl of
total RNA was retro-transcribed into cDNA using High Capacity
cDNA Reverse Transcription Kit (Thermo Fisher Scientific),
which is based on a combination of oligo(dT) and random
primers, following manufacturer’s instruction.
Amplification and Sequencing of the Myostatin cDNA
A nested PCR was developed, with external forward and reverse
primers falling in the 5′UTR and 3′UTR, respectively. The primer
sequences were:
• Forward 5′CCTTGGCATTACTCAAAAGCAA3′
• Reverse 5′CCTAAGTTTTCGAGCTAGGAGATC3′
The PCR conditions were: initial step at 95◦C for 2 min;
35 cycles of a three-step thermal profile of 95◦C for 30 s
(denaturation), 57◦C for 30 s (annealing), 72◦C for 60 s
(elongation); a final elongation step at 72◦C for 5 min.
Internal primers were:
• Forward 5′CAGTACGATGTCCAGAGAGATGACA
GCAGT3′
• Reverse 5′TGTGCACCAAGCAAACCCCAGAGGTT
CGGC3′
The PCR conditions were: initial step at 95◦C for 2 min;
35 cycles of a three-step thermal profile of 95◦C for 30 s
(denaturation), 61◦C for 30 s (annealing), 72◦C for 60 s
(elongation); a final elongation step at 72◦C for 5 min.
For both reactions, 3 µl of cDNA were added to a solution of
12.5 µl Master Mix (Multiplex PCR Kit, QIAGEN), 1 µl of each
primer (Forward and Reverse), 7.5 µl water. After separation
on a 2% agarose gel, PCR products were excised from the
gel, purified using the QIAquick Gel Extraction Kit (QIAGEN)
and sequenced on both directions with internal primers, using
the Sanger method.
Sequences Alignment
Sequences obtained via Sanger method (RACE PCR and
cDNA amplicons, see above) were aligned using ClustalOmega
(Sievers et al., 2011).
Precursor Prediction
The SignalP 4.11, the Combined Signal Peptide Predictor
(CoSiDe)2 and the Signal-3L 2.03 online tools were interrogated
for predicting the most probable location of the signal
peptide cleavage site.
Comparative Protein Modeling
Myostatin orthologs were searched through and sampled from
Mammalia. The crystallized structure of the myostatin was
available under the PDB_ID 5ntu (Cotton et al., 2018). The
retrieved sequences, including the proposed crystallized structure
1http://www.cbs.dtu.dk/services/SignalP/
2http://sigpep.services.came.sbg.ac.at/coside.html
3http://www.csbio.sjtu.edu.cn/bioinf/Signal-3L/
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(5ntu.pdb), were thus aligned by using ClustalW (see Pierri et al.,
2010, and references therein) for investigating chemical-physical
properties of the amino acid regions showing variants between
the human and the dromedary sequences. Accession numbers of
the sequences considered in this study, together with additional
details concerning the databases and the online tools used in this
study, are summarized in Supplementary Table S1.
Then, SPDBV was used for generating a 3D model of the
dromedary myostatin protein according to protocols described
in Pierri et al. (2010). The obtained 3D comparative model
was energetically minimized. A total of 100 steps of energy
minimization were performed for relaxing the obtained 3D
model by using the energy minimization tools implemented in
Chimera. WhatIF and Chimera biochemical tools were used
for checking the correct 3D model packing. PyMOL was used
for manual inspection of the investigated 3D models and for
generating figures (see Pierri et al., 2010, and references therein).
Phylogenetic Analysis
The analysis of the evolutionary relationships among orthologous
myostatin sequences was conducted using MEGA5 (Tamura
et al., 2011). Orthologous sequences of myostatin/growth
differentiation factor 8 with E-value lower than 10ˆ-55, query
coverage higher than 70% and % of identical amino acids
ranging between 40 and 100% were aligned by using ClustalW
implemented in Jalview. For Arthropoda, Aves, and Mammalia,
due to the existence of more than one hundred of sequences
complying with the above criteria, we imposed a filter on the first
30 sequences for each taxonomic group. Redundant sequences
with 100% identical amino acids were removed from the multiple
sequence alignment. A final set of 83 protein sequences (see
Supplementary Data Sheet S1) were retained for tree building.
In detail, the tree was built from the ungapped multiple sequence
alignment applying the maximum likelihood method with the
JTT model for the amino acid substitutions and a gamma
distribution (five discrete gamma categories) for the rates among
sites. A total of 100 bootstrap samplings were applied to test the
robustness of the tree.
Polymorphism Analysis
Sample Collection and Whole-Genome Sequencing
Whole blood from 25 Old World camels was collected during
routine veterinary procedures or as part of a monitoring
program of the wild camel population in Mongolia. These
samples included nine dromedaries (C. dromedarius), seven
domestic Bactrian camels (C. bactrianus), and nine wild camels
(C. ferus). Dromedary camels were selected to represent a variety
of geographic locations: Pakistan (1), Kenya (1), Kingdom of
Saudi Arabia (3), Sudan (1), United Arab Emirates (1), Qatar
(1), Canary Islands – Spain (1). Domestic Bactrian camel
originated from Mongolia or Kazakhstan, while all the wild
camels originated from Mongolia. DNA was extracted using
the Master PureTM DNA purification kit for blood (Epicentre
version III) and generated a 500 bp paired-end library for
each sample. Each library was sequenced with a single lane
of an Illumina HiSeq (Illumina, United States) according to
standard protocols.
Whole-Genome Read Processing and Alignments
The 3′ end of sequence reads were trimmed to a minimum phred-
scaled base quality score of 20 (probability of error < 1.0%)
and trimmed reads < 50 bp in length were excluded using
POPOOLATION v1.2.2 (Kofler et al., 2011). All processed reads
were aligned to the C. ferus CB1 reference genome (Genbank
accession: AGVR01040332.1) using BWA v0.6.2 (Li and Durbin,
2009) with parameters ‘−n 0.01 −o 1 −e 12 −d 12 −l 32.’
Duplicate reads were removed and alignments were filtered to
only include reads that were properly paired and unambiguously
mapped with a mapping quality score > 20. Reads around
insertions/deletions were realigned and a base quality score
recalibration was performed using the Genome Analysis Toolkit
(GATK) v3.1-1 following guidelines presented by Van der
Auwera et al. (2013). As input into the base quality score
recalibration step, a stringently filtered set of single nucleotide
variants (SNVs) was generated using the overlap of three
different variant-calling algorithms [SAMTOOLS v1.1] (Li et al.,
2009); [GATK HAPLOTYPECALLER v3.1-1] (Van der Auwera
et al., 2013); [ANGSD v0.563] (Korneliussen et al., 2014). The
overlapping SNVs were filtered to exclude those with a quality
score (Q) < 20, depth of coverage (DP) > 750 (∼30X/individual),
quality by depth (QD) < 2.0, strand bias (FS) > 60.0, mapping
quality (MQ) < 40.0, inbreeding coefficient < −0.8, mapping
quality rank sum test (MQRankSum) <−12.5, and read position
bias (ReadPosRankSum) < −8.0. Furthermore, SNVs were
excluded if three or more were found within a 20 bp window,
were within 10 bp of an insertion/deletion, or were found in an
annotated repetitive region.
Whole-Genome Variant Identification
Another set of SNVs from the realigned and recalibrated
alignment files was generated using the GATK
HAPLOTYPECALLER and filtering criteria as described
above. SNVs on scaffolds putatively assigned to the X and Y
chromosome, with a minimum allele count < 2, missing a
genotype in more than five individuals, with 4 > DP > 30 per
genotype, and deviating from Hardy–Weinberg equilibrium
(p < 0.0001) in VCFTOOLS v0.1.12b (Danecek et al., 2011)
were further excluded. This set of SNVs was used as a training
set to perform variant quality score recalibration in GATK,
assigning a probability of error to the training set of 0.1. This
recalibration develops a Gaussian mixture model across the
various annotations in the high-quality training dataset then
applies the model to all variants in the initial dataset. The process
has been shown to outperform the ‘hard’ filtering of variants (e.g.,
Pirooznia et al., 2014). After variant recalibration, all SNVs with
LOD score <−5.0 and 4 > DP > 30 per genotype were excluded.
Identification and Characterization of Variants at the
Myostatin Locus
The publicly available Camelus ferus myostatin sequence
(GenBank Accession No AGVR01040332) was BLASTed against
our Old World camel genomes and the contig-8645394
(Camelus dromedarius), contig-8938518 (Camelus bactrianus)
and contig-7907533 (Camelus ferus) were retrieved and used
in the comparative analysis of the myostatin locus at the
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nucleotide level. Moreover, from the final set of SNVs
described in the sub-section above, the Camelus dromedarius
Single Nucleotide Polymorphisms (SNPs) falling in the contig-
8645394 (Supplementary Data Sheet S2) were selected for
further inspection.
Bayesian Clustering
The identified SNPs were used for clustering the nine dromedary
samples by adopting the Bayesian algorithm implemented in
the STRUCTURE software v. 2.2 (Falush et al., 2007). The
analysis was performed without providing a priori information
on population membership, adopting the “admixture model”
option and a burn-in period of 10,000 generations, followed by
100,000 iterations. Five independent runs were performed for
each K value (number of clusters to be tested), and the results
were visually inspected for reproducibility. K values ranging
from 1 to 9 were tested, and the K value showing the highest
probability was discussed.
In silico Functional Prediction
The web-based analysis tool by the Human Splicing Finder
Version 3.0.2 (Desmet et al., 2009), available at http://
www.umd.be/HSF3/index.html, was used to predict putative
functional effect of SNP variants in terms of potential
alteration of splicing patterns. The in silico tool TFBIND
(Tsunoda and Takagi, 1999), available at http://tfbind.hgc.jp/,
was used to identify transcription factor binding sites (TFBS)
and their possible disruption due to the presence of Single
Nucleotide Polymorphisms.
Absolute Quantification of Myostatin
Transcripts
RNA Isolation and cDNA Synthesis
Skeletal muscles were sampled at slaughterhouses (Kingdom of
Saudi Arabia) from two adult animals. For each animal, eight
muscles, representative of the different anatomical regions of the
body were taken: brachiocephalicus (head/neck), deltoid, extensor
carpi radialis, and tensor fasciae latae (forelimbs), semitendinosus
and coccygeus (trunk), biceps femoris, and peroneus longus
(hindlimbs). For all muscles, sampling occurred within 30 min
post-mortem. Immediately after collection, samples were stored
in tubes containing RNAlater (QIAGEN). For RNA isolation and
cDNA synthesis, the procedures described above were adopted.
Digital Droplet PCR Assay Design
The Digital Droplet PCR method is based on end-point
fluorescence signal detection, and the intensity of signal observed
for positive droplets, varying with primer/template combination,
is not considered for target quantification. However, in this
system, droplets are interpreted as either “positive” or “negative,”
depending whether target amplification occurred or not, based
on a settled fluorescence cut-off. Two different assays, with
probes targeting the two possible exon junctions in the myostatin
gene (between exon 1 and 2, and between exon 2 and 3), were
used. FAM- (6-carboxy-fluorescein) and HEX- (hexa-chloro-
fluorescein) labeled probes were used, respectively, in Assay 1 and
Assay 2. Probes and primers sequences were as follows:
• Assay 1:
Probe 1 5′-/56-FAM/CTACAGAGT/ZEN/CTGATCTTCT
AATGC/3IABkFQ/-3′
Primer 1 5′-GACGGAAACAATCATTACC-3′
Primer 2 5′-GAGCTAAACTTAAAGAAGCAA-3′
• Assay 2:
Probe 1 5′-/5HEX/AAGGGATTC/ZEN/AAACCATCTT
CTC/3IABkFQ/-3′
Primer 1 5′-GGTCATGATCTTGCTGTA-3′
Primer 2 5′-GTCTGTTACCTTGACTTCTA-3′
By partitioning the reaction volume into thousands of
droplets, this technique allows absolute quantification of nucleic
acids without the need of a standard curve, with improved
precision over classical quantitative PCR (qPCR).
Digital Droplet PCR Conditions
A 20-µl reaction mixture was prepared comprising of 10 µl
ddPCR SupermixTM for probes (no dUTP) (Bio-Rad), 1 µl
primers and probe mix for Assay 1, 1 µl primers and probe mix
for Assay 2, 2 µl cDNA, 6 µl RNase-/DNase-free water. The
final concentration of primers and probe was 900 and 250 nM,
respectively. The amplification conditions were 10 min DNA
polymerase activation at 95◦C, followed by 40 cycles of a two-step
thermal profile of 30 s at 94◦C for denaturation, and 60 s at 60◦C
for annealing and extension, followed by a final hold of 10 min
at 98◦C for droplet stabilization, and cooling to 4◦C. A thermal
cycler (T100TM; Bio-Rad) was used, and the temperature ramp
rate was set to 2◦C/s, with the lid heated to 105◦C, according
to the Bio-Rad recommendations. A negative (no template) and
a positive control were included. The latter consisted, for both
assays, of a synthetic oligonucleotide (gBlocks Gene Fragment,
by IDT), with a size of 467 bp, including junctions between
exons 1 and 2 and between exons 2 and 3, designed based on
the predicted sequence for the myostatin transcript in Camelus
dromedarius (XM_010991955). In the reaction preparation, for
the positive control, 2 µl of the above synthetic oligonucleotide
were added, at a final concentration of 1 ng/ml. For all the
considered muscles, two biological and two technical replicates
were included in the experiment.
Data Analysis
After the thermal cycling, the plates were transferred to a droplet
reader (QX200TM; Bio-Rad). The software package provided with
the ddPCR system was used for data acquisition (QuantaSoftTM
1.6.6.0320; Bio-Rad). The rejection criterium for the exclusion of
a reaction from subsequent analysis was a low number of droplets
measured (<10,000 per 20 µl PCR). The data from the ddPCR are
given in target copies/µl reaction. The significance of differences
among muscles was tested using ANOVA (Analysis of Variance).
Protein Extraction and Western Blotting
A small sample of frozen muscle tissue (100 mg), previously
stored in tubes containing RNAlater (QIAGEN), was finely
chopped and homogenized by using a sharp scalpel in 300 µl
Ripa buffer [10 mM Tris-HCl pH 7.4, 140 mM NaCl, 1% (v/v)
Triton X-100, 1% (w/v) Na-deoxycholate, 0.1% (v/v) SDS, 1 mM
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NaF, 1 mM EDTA, 1 mM Na3VO4] supplemented with 1x
protease inhibitor cocktail (Sigma), and then by using the T 10
basic Ultra-Turrax homogenizer (IKA). After homogenization,
the sample was kept on ice for 30 min, and then vortexed
for 5 min. At the end, sample was centrifuged for 20 min
at 4◦C at 13,000 × g to remove unbroken cells, nuclei and
cell debris. The supernatant, containing solubilized proteins,
was recovered and protein concentration was measured by the
method of Bradford (Bradford, 1976). An aliquot of 20 µg
of protein for each sample was diluted in Laemmli buffer
not containing DTT or β-mercaptoethanol, heated at 95◦C
for 5 min, and separated by 12 % (v/v) Tris/HCl SDS/PAGE.
The separated proteins were transferred to Immobilon P
(Millipore) in Trans-Blot semidry electrophoretic transfer cell
(Amersham Biosciences) for immunoblotting. The used primary
antibody was a rabbit polyclonal anti-MSTN antibody against the
C-terminal region (300–349 aa) of mouse myostatin (TA343358,
OriGene; dilution 1:1000) that presented broad species reactivity,
including artiodactyls. The densitometric quantification and
image processing of the considered bands were carried out
using Adobe Photoshop and the Image software package
(version 1.61, National Institutes of Health, Bethesda, MD,
United States). The total lane density of transferred proteins
on the membrane stained with Coomassie Blue dye was used
for the normalization of the proteins of our interest. The
significance of differences among muscles, for each considered
band, was tested using ANOVA (Analysis of Variance). Post
hoc t-tests were performed to determine where the groups
differed. All p-levels for post hoc t-tests were adjusted using
Bonferroni correction.
RESULTS
Myostatin Gene Organization
The RACE-PCR approach allowed to map the start transcription
site (Supplementary Figure S1A) at 109 bp upstream the
start-codon, in a position that is 24 and 25 bp downstream
compared to the usual human and mouse transcription
initiation sites, respectively4. The transcriptional termination site
(Supplementary Figure S1B) was mapped 215 bp downstream
the stop-codon, much earlier than in human and mouse where
a 1561 and 1448 bp 3′UTR is usually reported4. No evidence
was found, by combined RT-PCR and RACE approaches,
for alternative splicing events or alternative 5′ or 3′ ends
(Supplementary Figure S2). Based on the above, a 5292 bp
genomic locus was identified for myostatin in C. dromedarius.
The locus was highly conserved among the three Old World
camelids species (Supplementary Figure S3). Comparative
analysis of the C. dromedarius genomic sequence (contig-
8645394) with the obtained cDNA sequences confirmed, as in
other species, the presence of three exons and two introns, with a
predicted C. dromedarius myostatin full length cDNA of 1452 bp
(Supplementary Figure S4A) and a protein of 375 amino acids
(Figure 1). The latter is consistent with the predicted protein
4http://genome-euro.ucsc.edu/index.html
size for most of the species5. The dromedary myostatin protein
also showed all the hallmarks present in other TGF-ß family
members, including an N-terminal signal sequence for secretion,
a pro-region followed by the proteolytic processing RSRR site,
and a C-terminal domain containing nine cysteine residues. In
particular, the signal peptide was consistently predicted to have
an 18 amino acid length by SignalP 4.1 and Signal-3L 2.0, while a
length of 23 amino acids was predicted by CoSiDe.
Comparative 3D Protein Modeling
Sequences from nine Artiodactyla species, including the three
phylogenetically close Old World camelids (C. dromedarius, C.
bactrianus, and C. ferus), one New World camelid (Vicugna
pacos), the two Bos taurus subspecies, i.e., B. taurus taurus (a
non “double muscle” Hereford subject) and B. taurus indicus,
the wild yak (Bos mutus), the buffalo (Bubalus bubalis) and
the bison (Bison bison) were aligned with the human myostatin
sequence (Accession no. ABI48419.1), and the human myostatin
C-terminal domain solved by X-ray diffraction (residues 46-375
out of 375) (Figure 2A). C. dromedarius, C. ferus, C. bactrianus,
and V. pacos share 100% of identical amino acids. Six, or
fourteen, variants are observed among the above cited Camelidae
sequences and the human myostatin sequence (Accession No.
ABI48419.1), or the corresponding taurine myostatin sequence,
respectively (Figure 2A). Out of them, 5 in the contrast with
the human sequence and 13 in the contrast with the taurine
sequence are variants occurring at different sites, while one,
at position 164, presented different variants when contrasted
with the human and the cattle sequence, respectively. In
addition, it is possible to observe that the 6 variants detected
in the contrast with the human sequence are conservative
(Figure 2A), while 9, out of the 14 variants detected in
the contrast with the cattle sequence are not conservative
(Figure 2A). No variants were observed when contrasting among
them the sequences from the five species belonging to the
Bovidae family. A notable exception was B. bubalis, for which
variants where observed at positions 101, 117 and 141. In
all the above cases, the nucleotides observed in B. bubalis
were different from those observed in all the other eight
sequences. Figure 2B presents the 3D comparative model of
the C. dromedarius myostatin dimer, and highlights the variants
observed between the Camelidae myostatin sequences and the
human/bovine myostatin.
Evolutionary Relationships Among
Myostatin Proteins
The inferred maximum likelihood tree of myostatin protein
sequences (Figure 3) highlighted the presence of three supported
clusters (bootstrap value higher than 60%), corresponding to
Arthropoda, Reptilia and Amphibia, that may reflect a different
attitude in the regulation of skeletal muscle growth in the
different taxonomic groups. Interestingly, within Mammalian
sequences, the highest bootstrap value (99%) was observed
for the cluster grouping myostatin sequences belonging to
the Bovidae family.
5https://www.uniprot.org/uniprot/
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FIGURE 1 | Amino acidic sequence of the C. dromedarius myostatin as inferred from the cDNA sequence. (A) Schematic outline. The three protein domains (signal
peptide, pro-region, and active peptide) are highlighted in different colors (yellow, blue, and green, respectively). The two most likely residues involved in the signal
peptide cleavage (see main text) are indicated by black arrows. Similarly, the residue (D, for aspartic acid) shown to be essential for BMP/tolloid protease cleavage,
and the motif (RSRR) needed for recognition by furin convertase, are highlighted. (B) Amino acidic sequence of the C. dromedarius myostatin, with the three protein
domains highlighted in different colors, as in (A). The above mentioned hallmarks are also depicted here (signal peptide cleavage, black arrows; BMP/tolloid protease
cleavage residue and furin convertase recognition motif, bold). In addition, the nine conserved cysteine residues in the active peptide are indicated (bold and white).
Polymorphism Analysis and in silico
Functional Prediction
The results of the sequence polymorphism analysis for the
myostatin locus are presented in Table 1. As can be observed, only
three polymorphisms, two transitions (A66460G and T66461C)
and one transversion (G66148C), were identified inside the
myostatin gene, all located deep in the intron 1. On the other
side, a total of 45 and 21 variant sites were identified in our
study in the upstream and downstream regions, respectively,
with an overall average density of one SNP every about 1.5 kb.
In order to interpret the observed patterns of SNP distribution
across samples from different countries, we performed a Bayesian
clustering analysis of the nine dromedary samples using the
69 identified SNPs. At K = 7 (Supplementary Figure S5), the
analysis highlighted that the sample from Pakistan was well
differentiated, and the same occurred for a pair of samples,
one from Kingdom of Saudi Arabia and one from United Arab
Emirates, respectively. The rest of the samples were clearly
“admixed,” suggesting that most of the considered SNPs do not
follow a geographic pattern. Putative variants in the myostatin
coding region, inferred from aligning previously published
myostatin sequences with sequences generated in this study, are
presented, for completeness, in Supplementary Figures S4A,B.
Analysis by Human Splicing Finder highlighted, for the
intronic polymorphisms, a potential role in alteration of
splicing for G66148C, predicted to break an ESE (exonic
splicing enhancer) site (Supplementary Figure S6A), A66460G,
predicted to generate a new donor site and a new ESS (exonic
splicing silencer) site (Supplementary Figure S6B), while no
significant splicing motif alteration was detected for T66461C
(Supplementary Figure S6C). TFBS analysis, performed for each
SNP using the two input sequences harboring the alternative
alleles, highlighted the presence of disrupted TFBSs for all
the three loci (Table 2). Moreover, we analyzed the potential
transcriptional factor binding sites in the DNA sequence of
8 kb of the C. dromedarius myostatin gene upstream region
(included in the contig-8645394). A total of 10677 putative
binding sites were identified (Supplementary Data Sheet S3).
A graphical outline of the most significant predicted regulatory
motifs in the 1.5 kb proximal to the transcription initiation
site of the C. dromedarius myostatin gene is presented in
Supplementary Figure S7. In addition, in this region two SNPs
were present (T63437C and A64026G) (Table 1), out of which
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FIGURE 2 | Comparative analysis of myostatin protein sequences. (A) The alignment of myostatin orthologous sequences sampled from various mammalian species
is presented. Blue arrowheads indicate the variants detected between the four considered Camelidae sequences and the five Bovidae sequences at 13 specific
sites. Black arrowheads indicate the variants detected between the four considered Camelidae sequences and the Homo sapiens sequence at 5 specific sites,
different from the sites previously cited. The gray arrowhead indicates the position of two different variants detected in H. sapiens and in Bovidae in correspondence
of Q164 from C. dromedarius. Orange “boxes” indicate variations between the H. sapiens sequence retrieved from refseq_database and the sequence of the human
crystallized myostatin. Amino acid codes and numbering refers to the C. dromedarius myostatin. (B) Lateral view of the 3D comparative model of the C. dromedarius
myostatin dimer. The protein is reported in green/magenta cartoon representation. Variants observed between Camelidae myostatin sequences and human/Bovidae
myostatin are reported in black (5)/blue (13) spheres in chain A, and dark-yellow (5)/cyan (13) spheres in chain B, respectively. The only site of C. dromedarius
myostatin showing a variation both in H. sapiens and in Bovidae locates at site 164 (Q164 for C. dromedarius, E164 in H. sapiens, K164 in B. taurus) and is
indicated by gray spheres. Notably, variants observed between C. dromedarius and Bovidae occur at different sites with respect to those detected between
C. dromedarius and H. sapiens, with the exclusion of residues at site 164. Residues C339/C340 of chain A and chain B, forming inter-monomer disulphide bridges,
are reported in red spheres. R65 of chain A and chain B, involved in interactions with T114, is indicated by red sticks.
the latter was also observed as being polymorphic by aligning
the contig-8645394 (Supplementary Data Sheet S2) with the
publicly available contig4726 (Accession No. JDVD01004726.1)
and contig_13989_126 (Accession No. LSZX01094446.1). TFBS
analysis, repeated for each SNP using the two input sequences
harboring the alternative alleles, suggested the disruption of
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FIGURE 3 | Phylogenetic analysis of myostatin protein sequences. Numbers indicate bootstrap values higher than 60/100.
one (NFKB_Q6) and three (COUP_01, MYB_Q6, and T3R_01)
transcription factors binding sites for loci T63437C and
A64026G, respectively (data not shown).
Quantitative Myostatin Transcript
Analysis in Dromedary Skeletal Muscles
We investigated the quantitative expression of myostatin
transcripts in eight dromedary skeletal muscles (deltoid,
extensor carpi radialis, coccygeus, biceps femoris, peroneus
longus, semitendinosus, tensor fasciae latae, brachiocephalicus)
by Digital Droplet PCR. Two different assays, with probes
targeting the two possible exon junctions in the myostatin
gene, were used. Number of droplets generated in each
experiment replicate, together with plot of raw data, are shown
in Supplementary Figure S8. All the replicates passed the cut-off
value (>10,000 droplets). Figure 4 presents the results of the
absolute quantification experiments for the eight muscles, and
for the two probes, expressed as target copies/µl. The FAM-
labeled probe (probe 1, targeting the junction between exon 1
and 2) produced systematically higher values compared to the
HEX-labeled probe (probe 2, targeting the junction between exon
2 and 3). However, trends among different muscles were similar
for both probes, as also supported by a correlation coefficient
higher than 0.78 (data not shown). Analysis of variance among
means of different muscles did not find significant difference for
any of the two assays.
Myostatin Protein Expression in
Dromedary Skeletal Muscles
We investigated the expression of myostatin at the protein
level on the same set of dromedary skeletal muscles previously
described for quantitative transcript analysis. In order to detect
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TABLE 1 | Single Nucleotide Polymorphisms identified in the considered population sample (nine C. dromedarius animals from seven countries).
Target region Size (bp) Polymorphism
Upstream 64736 G13066T; T13901A◦; C14568A◦; T14745G; C16352T; G16640A◦; G17867A; T25076C◦;
T29288A; G31182A; G31464A; C32869T◦∗; C33308G; G33597C; G34295T; T34901C◦∗;
G35625A◦∗; C35782T◦; G38778A; T40104C◦∗; T41149C∗; T42365A; C43439A◦; C47473T;
C48225T; G48931T◦∗; C49083T∗; G49630C◦∗; T50414C; T50514G∗; A50637C◦; T50897C∗;
T52618C◦; G52669T; T53222C◦∗; G53398A◦∗; C55949T◦∗; A56391G; G57208A◦∗; T58686C◦∗;
G59091T◦∗; A59187T∗; A60587G; T63437C; A64026G◦∗
5′ UTR 109 None
Exon 1 373 None
Intron 1 1801 G66148C◦; A66460G∗; T66461C∗
Exon 2 374 None
Intron 2 2039 None#
Exon 3 381 None
3′ UTR 215 None
Downstream 21956 A72141T; A72526G; A73136C; G75845A◦∗; T75862C; G76270A◦∗; T77354C◦∗; T78572A;
G78774A◦; G78993A∗; T80531G; C81364T◦; C81499T◦; G83533C; T86423C◦; T87060A◦;
G89595A◦; A89886T; C90627A◦; A90686T; T90834C◦
Variant sites are presented based on the region where they are located (either in the exons or introns of the myostatin locus, in the 5′ or in the 3′ UTR, or in the
upstream/downstream regions). Site positions refer to the C. dromedarius contig-8645394. Circles (◦) indicates those SNPs that could also be observed when aligning
the contig-8645394 with the publicly available contig4726 (Accession No. JDVD01004726.1). Asterisks (∗) indicates those SNPs that could also be observed when
aligning the contig-8645394 with the publicly available contig_13989_126 (Accession No. LSZX01094446.1). The # (hash) symbol indicates the only SNP, located in the
myostatin gene (intron 2), that was not observed in our study but was evident when aligning the contig-8645394 with both contig4726 and contig_13989_126.
the active C-terminal myostatin dimer, we performed Western
Blot analyses using a polyclonal antibody raised against the
C-terminus. Moreover, protein electrophoretic separation was
run under non-reducing conditions in order to preserve the
integrity of the disulphide bonds in the C-terminal domain.
As shown in Figure 5A, a major band is present at an
apparent molecular mass of 75 kDa, corresponding to the
expected mass for the promyostatin dimer. Additional, weaker
bands were observed at around 40 and 25 kDa, corresponding
to the promyostatin monomer and the active C-terminal
myostatin dimer, respectively. Densitometric analysis of Western
Blots, performed on five different protein extracts for each
muscle, highlighted significant differences (ANOVA, p = 0.0001)
among muscle types for the promyostatin dimer (Figure 5B),
while no significant difference was observed for both the
promyostatin monomer and the active C-terminal myostatin
dimer, respectively (Figure 5B). Post hoc tests highlighted four
significant (p < 0.0017) pair-wise comparisons, all of them
involving the tensor fasciae latae muscle (vs. deltoid, extensor
carpi radialis, coccygeus, and brachiocephalicus).
DISCUSSION
Myostatin Gene Organization and
Protein Comparative Modeling
The myostatin gene has been largely studied in several livestock
and model species. Very recently, the gene has been mapped
to chromosome 5 in Camelus dromedarius (Elbers et al.,
2019). By combining experimental and in silico approaches,
we here describe, for the first time, the gene organization
and the protein structure in the one-humped Old World
camelid species. We confirmed the major features observed
in other species for the myostatin gene. As expected, a high
sequence similarity was observed among our experimentally
obtained transcript sequence for C. dromedarius myostatin
and the publicly available predicted sequences for the other
two species within the Camelus genus, in line with the
relatively recent divergence times between them, estimated in 5–
8 mya between one-humped and two-humped domestic camels
(Wu et al., 2014), and about 0.7 million years ago between
C. bactrianus and C. ferus (Ji et al., 2009). Also, myostatin
orthologs showed a high percentage of identical amino acids
through Mammalia, which may explain the low bootstrap values
observed in the maximum likelihood tree. A notable exception
was represented by the Bovidae sequences, that clustered with
high bootstrap values. Peculiar selection constraints may have
played a role in shaping the evolutionary history of myostatin
in Bovidae. Indeed, besides the well documented human-
mediated positive selection experienced in recent times by the
Bos taurus myostatin gene, particularly in specialized beef breeds,
evidence for a more remote action of positive selection on
this gene, operating during the time of divergence of Bovinae
and Antilopinae, has been produced by Tellgren et al. (2004)
in a systematic analysis of myostatin sequence evolution in
ruminants. These periods of positive selective pressure on
myostatin may correlate with changes in skeletal muscle mass.
In fact, the early bovid fossil record, dating back to around 17
million years ago, had a body mass estimate of only around
20 kg. Hence, the hypothesis is that selective pressures on
myostatin drove this increase in body mass coupled to an
increase in skeletal muscle mass, in turn driven by ecological
changes in the environments of the various species. In a recent
paper, the phylogenetic relationships between camelids and
other mammalian species were investigated using whole-genome
sequence data (Wu et al., 2014). The authors report estimated
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divergence time between camelids and cattle lower than those
between other mammals. This seeming discrepancy with our
results may arise from the fact that single gene phylogenies
could not reflect the complex evolutionary history of a whole
genome and they could be less reliable in inferring genome-
scale events.
Myostatin protein consists of a non-covalently held complex
of the N-terminal propeptide and a disulfide-linked dimer
of C-terminal fragments (Lee and McPherron, 2001).
Variants detected respectively in B. taurus and H. sapiens,
in correspondence of the C. dromedarius K49 and L53 may
be involved in the stability of the myostatin dimer due to
their location close to the disulphide bonds occurring among
C339 and C340 residues at the myostatin dimer interface
(Jiang et al., 2004). Notably, the myostatin N-terminal domain
contains a region (residues 49–67) highly similar to the key
latency-determining regions of the TGF-β superfamily (Walton
et al., 2010). Thus, it is expected that variations observed in our
comparative analysis at this region, above all in correspondence
of the C. dromedarius K49 (Thr in B. taurus myostatin, Lys
in TGF-β1) and L53 (Ile in H. sapiens myostatin, Leu in TGF-
β1) may contribute toward its latency, according to Walton
et al. (2010). More in general, all the cited variants locate at
the monomer/monomer interface. Notably, we observed, in
Camelidae myostatin sequences, not conservative substitutions
compared to the B. taurus taurus myostatin sequence at position
49 (Lys in C. dromedarius; Thr in B. taurus), 88 (Arg in
C. dromedarius; Leu in B. taurus), 100 (Asp in C. dromedarius;
Ala in B. taurus),114 (Thr in C. dromedarius; Arg in B. taurus),
129 (Met in C. dromedarius, Thr in B. taurus), 167 (Thr in
C. dromedarius, Ala in B. taurus), 243 (Gly in C. dromedarius;
Glu in B. taurus), 356 (Lys in C. dromedarius; Glu in B. taurus),
357 (Glu in C. dromedarius, Gly in B. taurus) that may produce
a different charge network in myostatin dimer, favoring different
monomer/monomer interactions. In particular, among the
described variants, it is worth noting that the residue at site 114
forms intra-chain binding interactions with Y111 and H112 and
inter-chain binding interactions with R65. R65, Y111 and H112
together with K153 (R153 in H. sapiens) were already described
as “fastener” residues associated with muscle- and obesity-related
TABLE 2 | Results of the TFBS analysis for the three intronic SNPs detected in this study.
SNP AC ID Score Strand Consensus Signal
A66460G Allele A
M00103 V$CLOX_01 0.778624 (+) NNTATCGATTANYNW GGTATTAATTAGCTG
M00104 V$CDPCR1_01 0.790948 (−) NATCGATCGS GGTATTAATT
M00134 V$HNF4_01 0.769283 (−) NNNRGGNCAAAGKTCANNN ATTTAAATTTTGGTATTAA
Allele G
M00211 V$PADS_C 0.825857 (+) NGTGGTCTC TTTGGTGTT
M00212 V$POLY_C 0.787056 (+) CAATAAAACCYYYYKCTN CATTTAAATTTTGGTGTT
M00279 V$MIF1_01 0.741931 (−) NNGTTGCWWGGYAACNGS GGTGTTAATTAGCTGCTA
M00280 V$RFX1_01 0.776836 (−) NNGTNRCNWRGYAACNN GTGTTAATTAGCTGCTA
G66148C Allele G
M00143 V$PAX5_01 0.787091 (+) NCNNNRNKCANNGNWGNRKRGCSRSNNN GAGACAGGCACCTTAACAGAGAAGGCAT
Allele C
M00262 V$STAF_01 0.767919 (+) NTTWCCCANMATGCAYYRCGNY TTAACACAGAAGGCATGACAAG
T66461C Allele T
M00103 V$CLOX_01 0.778624 (+) NNTATCGATTANYNW GGTATTAATTAGCTG
M00104 V$CDPCR1_01 0.790948 (−) NATCGATCGS GGTATTAATT
M00252 V$TATA_01 0.829231 (+) STATAAAWRNNNNNN GTATTAATTAGCTGC
Allele C
M00185 V$NFY_Q6 0.779548 (−) TRRCCAATSRN CTAATTAGCTG
AC, transcription factor matrix code. ID, transcription factor label, with V meaning “vertebrate.” SCORE, similarity (0.0–1.0) between a registered sequence for the
transcription factor binding sites and the input sequence. STRAND, strandness. + and − means forward and reverse strands that the transcription factor binds,
respectively. CONSENSUS, consensus sequence (fixed) of the transcription factor binding sites. S = C or G, W = A or T, R = A or G, Y = C or T, K = G or T, M = A or C,
N = any base pair. SIGNAL, sub-sequence from the input sequence at the position corresponding to the consensus sequence. Default cut-offs by Tsunoda and Takagi,
1999 were adopted. The analysis was performed, for each SNP, using the two input sequences harboring the alternative alleles.
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FIGURE 4 | Absolute quantification of the myostatin transcript in skeletal muscles. Results of the Digital Droplet PCR analysis for the eight considered dromedary
muscles (1, deltoid; 2, extensor carpi radialis; 3, coccygeus; 4, biceps femoris; 5, peroneus longus; 6, semitendinosus; 7, tensor fasciae latae; 8, braciocephalicus)
and for the two used probes (u, Probe 1; u, 2 Probe 2) are presented as mean ± SD of the four replicates.
phenotypes (Gonzalez-Freire et al., 2010; Santiago et al., 2011;
Bhatt et al., 2012; Garatachea et al., 2013; Szlama et al., 2015).
Furthermore, variations of the residue at site 100 may influence
the release of the active form from the myostatin propeptide
complex due to its location close to the myostatin propeptide
TLD cleavage target site (consisting of the dipeptide 98-RD-99)
(Szlama et al., 2013).
Genetic Sequence Polymorphism and
Functional Prediction
Unexpectedly, the Next Generation Sequencing (NGS) of the
whole myostatin locus in nine dromedaries from a variety
of geographic locations in Asia, Africa and Europe did
not allow the identification of novel intra-genic variants
and only confirmed the presence of the three SNPs in
intron 1 previously identified by Muzzachi et al. (2015)
via Sanger-sequencing of a reduced portion of the gene
on a different set of Northern African dromedaries. This
result seems to support the hypothesis, formulated by
Muzzachi et al. (2015) that the low diversity observed at
the myostatin locus in Camelus dromedarius may reflect
the peculiar evolutionary history of this species, which
likely developed as domesticates from a low variable wild
ancestor population.
Evidence about the existence of functional variants located
in introns is growingly accumulating (Lee et al., 2015; Mou
et al., 2015; Hong et al., 2018; Ostrovsky et al., 2018),
not only restricted to exon–intron boundaries but also in
deep intronic regions (Mendes de Almeida et al., 2017; Vaz-
Drago et al., 2017). The three intronic SNPs detected in
this study were in silico predicted to have the potential of
altering both splicing and TFBS, thus suggesting they may
play a role in myostatin processing and/or regulation. TFBS
analysis in the myostatin upstream region allowed to predict
several potential transcriptional factor binding sites, mainly
belonging to the large family of dimerizing transcription
factors harboring a basic helix-loop-helix (bHLH) structural
motif, such as MYOD (myogenic differentiation), MYOG
(myogenin), MYC (myelocytomatosis viral oncogene), MAX
(MYC Associated Factor X), TAL1 (T-Cell Acute Lymphocytic
Leukemia), SREBP (Sterol Regulatory Element-Binding Protein),
AHR (Aryl Hydrocarbon Receptor), ARNT (Aryl hydrocarbon
receptor nuclear translocator), HEN (Nescient Helix-Loop-
Helix 1), HLF (Hepatic Leukemia Factor), USF (Upstream
Transcription Factor) (Jones, 2004; Sailsbery and Dean, 2012).
Out of them, MYOD and MYOG belong to the myogenic
regulatory factor (MRF) family known to play key roles
in the determination and differentiation of skeletal muscle
(Botzenhart et al., 2018). Besides them, a role in regulating
myostatin expression has been largely demonstrated for CREB
(Xie et al., 2018), MEF (Bo Li et al., 2012; Estrella et al.,
2015) and C/EBP (Allen et al., 2010; Deng et al., 2012),
for which potential binding sites were also detected in our
in silico analysis of the dromedary myostatin gene upstream
sequence. Moreover, in the about 400 bp region upstream
to the transcriptional start site, three TATA boxes and one
CCAAT box were observed, consistently with previous reports
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FIGURE 5 | Myostatin protein expression. (A) Representative Western Blot of the eight considered dromedary muscles (1, deltoid; 2, extensor carpi radialis; 3,
coccygeus; 4, biceps femoris; 5, peroneus longus; 6, semitendinosus; 7, tensor fasciae latae; 8, brachiocephalicus) performed using a rabbit polyclonal antibody
(1:1000 dilution) that specifically binds the carboxy-terminal domain (Origene, TA343358). (B) Western Blot densitometric analysis of the promyostatin dimer
(75 kDa), the promyostatin monomer (40 kDa) and the active C-terminal dimer (25 kDa), respectively. For each lane, optical density (OD) of the considered band is
presented as a ratio over the total density of all the proteins transferred on the membrane and stained with Coomassie blue.
by Spiller et al. (2002) in the bovine species and Du et al.
(2011) in the ovine species. On the contrary, in the above
region, we detected four E-boxes, unlike (Spiller et al.,
2002) and (Du et al., 2005), who detected three and five
E-boxes, respectively.
Most of the variants detected in our population sample,
representative of seven different countries across the African
and the Euro/Asiatic continent, could be also detected by
aligning our Camelus dromedarius contig-8645394 with contigs
available in public databases, representative of animals of
African and Asiatic descent (Accession No. LSZX01094446.1,
from a Targui animal sampled in Algeria, and Accession No.
JDVD01004726, from an animal sampled in the Kingdom of
Saudi Arabia, respectively). This result suggests that (i) our
population sample, despite being limited in size, could be
considered as providing a good representation of the species
genetic diversity, and (ii) a limited differentiation may exist also
among geographically distant samples, as pointed out by the
preliminary results of the first world-wide Camelus dromedarius
genetic diversity survey performed using genome-wide RAD-
sequencing (Ciani et al., 2017)6, and in line with the known
recurrent gene flow at ancient trading centers along the caravan
routes (Almathen et al., 2016).
Myostatin Expression Profiling in
Skeletal Muscles
In order to quantify the level of myostatin transcript in
dromedary skeletal muscle, we adopted a Digital Droplet
6https://pag.confex.com/pag/xxv/meetingapp.cgi/Paper/23709
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PCR approach. In our experiments, we used two different
probes designed on the two exon-junctions of the myostatin
gene and differentially dye-labeled. The FAM-labeled probe
gave systematically higher values compared to the HEX-
labeled one. This result agrees with the known evidence
that FAM has a stronger signal compared to other dyes.
Indeed, this feature may determine a larger number of
droplets, where target amplification occurred for both assays,
to be designed as “positive” for the FAM-labeled probe
compared to the HEX-labeled probe at a given fluorescence
threshold. Alternatively, a different absolute quantification in
a two-probe system targeting the same gene may arise from
the presence of alternative transcripts that may reduce the
amplification/detection efficiency of one of the two assays,
but not necessarily both. However, in our study, given the
systematic and consistent differences between the two assays
across eight different skeletal muscles, a major role for the
alternative transcript phenomenon appears rather unlike. Finally,
we cannot exclude a minor role of stochastic factors in affecting
the observed results.
In our experimental conditions, no significant differences
were observed for the eight considered muscles by any of the
two assays. These results are in line with those previously
published by Morrison et al. (2014) who did not find
significant variation in myostatin expression levels, assessed
via Quantitative Real-time PCR, among four skeletal muscles
(rectus abdominis, longus colli, adductor, pectoralis transversus)
in the horse species. A similar scenario was observed in this
study also at the protein level where no significant difference
was observed among muscle types for the three myostatin
forms (25, 40, and 75 kDa), with the exception of four pair-
wise comparisons, all involving the tensor fasciae latae muscle,
where a significantly lower expression was observed only for
the promyostatin dimer. For the other two myostatin forms,
tensor fasciae latae displayed weaker bands although they did
not reach significance when contrasted to other muscles. The
generally low expression of the three myostatin forms in the
tensor fasciae latae muscle tempted us to speculate about a
possible relationship with the fiber type composition of this
muscle, which has been reported, in various species, to be
mainly of the fast glycolytic type (Ariano et al., 1973; Abe
et al., 1987; Manabe et al., 2000; Sazili et al., 2005; Bakou
et al., 2015). In fact, some authors previously reported about a
negative correlation between myostatin and the fast phenotype
of skeletal muscles (Bouley et al., 2005; Hennebry et al., 2009;
Baan et al., 2013). However, muscle phenotypes may be affected
by many endogenous and exogenous factors, such as stage of
maturity (Kugelberg, 1976), level of activity (Goldspink, 1983),
different sampling regions of the same muscle (Torrella et al.,
2000), histological method (Karlsson et al., 1999). Hence, the
known large variability of muscle fiber phenotypes, coupled
to the lack of specific data for the dromedary camels, makes
it hazardous to extend the mentioned correlation to the
species under study.
In general, densitometric analysis highlighted that the
promyostatin dimer is the most expressed form in all the
considered muscles while the active myostatin has the lowest
level of expression. The above results fit well with multiple
evidences that, in muscle, myostatin resides primarily as
unprocessed promyostatin (Anderson et al., 2008; Pirruccello-
Straub et al., 2018) and that the active mature growth
factor is significantly less abundant in this compartment
(Hill et al., 2002, 2003; Zimmers et al., 2002; Anderson
et al., 2008; Lakshman et al., 2009). Moreover, it must be
pointed out that the observed 25 kDa bands, suggestive of
the active myostatin form, could, in our study, reflect the
amount of myostatin dimers, deriving from the latent complex
generated by furin cleavage, and artificially “activated” by the
experimental SDS environment (Wehling et al., 2000), rather
than reflecting a physiologically activated form. Based on
the above, the unprocessed or partially processed myostatin
dimers could act as important reservoirs of slowly available
myostatin forms, and the sequential cleavage steps contribute
an additional layer of control, within an already complex
regulatory framework.
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FIGURE S1 | Electropherograms of 5’ and 3’ RACE PCR products. (A) Partial
sequence of the 5’ untranslated region (UTR) of the C. dromedarius myostatin
transcript, together with a partial sequence of the universal oligonucleotide
provided in the SMARTer RACE cDNA amplification kit (Clonetech). (B) Partial
sequence of the 3’ untranslated region (UTR) of the C. dromedarius myostatin
transcript, together with part of the poly(A) tail.
FIGURE S2 | RACE PCR products separated via 2% agarose gel electrophoresis.
The upper arrow corresponds to 366 base pairs, while the lower arrow
corresponds to 316 base pairs.
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FIGURE S3 | Comparative analysis of the myostatin genomic locus in the three
Old World camelid species. Dromedary, C. dromedarius (contig-8645394). Wild
camel, C. ferus (contig-7907533). Bactrian camel, C. bactrianus
(contig-8938518). Highlighted, in the C. dromedarius sequence, the 5’ and 3’ UTR
regions (light blue) and the three exons (yellow).
FIGURE S4 | Putative SNPs in the myostatin coding region, as inferred from
alignment among previously published myostatin sequences and sequences
generated in this study. (A) Consensus sequence of the myostatin coding region.
Highlighted, in yellow, the exonic region, and, in red, the variant sites. Numbering
of polymorphism positions refers to the contig AGVR01040332. (B) Summary
table of the inferred polymorphisms showing the nature of the putative variants,
together with the reference literature, and the prediction of the variant effects (in
case of a missense mutation, the alternative amino acids are reported, otherwise
“none” is entered).
FIGURE S5 | Plot of the Bayesian clustering analysis perfoemed on the nine
considered dromedaries using the 69 identified SNPs. The plot shows the results
obtained for K = 7, that was identified as the most likely output by visual
inspection of the probability values associated to each tested K value (from 1 to 9).
Numbers indicate different samples (1, United Arab Emirates; 2, Qatar; 3-4-5,
Kingdom of Saudi Arabia; 6, Austria; 7, Kenya; 8, Sudan; 9, Pakistan). Colors
indicate the seven different clusters. The proportion of each individual sample in
each inferred cluster is shown in the y-axis.
FIGURE S6 | Results of the Human Splicing Finder analysis for the three intronic
SNPs detected in this study. (A) G66148C. (B) A66460G. (C) T66461C.
FIGURE S7 | Graphical outline of the major predicted regulatory motifs in the
1.5 kb proximal to the transcription initiation site of the C. dromedarius myostatin
gene. TATA boxes (highlighted in yellow), E-boxes (highlighted in gray), CREBP1
(light green), CREB_01 (orange), MYOGNF1 (blue), CEBP_01 (purple), MEF (pink),
MYOD (dark green), and the CCAAT box (highlighted in purple) are presented.
FIGURE S8 | Graphical evaluation of the Digital Droplet PCR performance. (A)
2D-dot plot of fluorescent signals detected in the Digital Droplet PCR experiments.
Fluorescence results are plotted as two-dimensional dot plots. Gray dots
correspond to empty droplets. Blue dots correspond to droplets containing at
least one copy of the sequence complementary to Probe 1. Green dots
correspond to droplets containing at least one copy of the sequence
complementary to Probe 2. Orange dots correspond to droplets containing at
least one copy of the sequence complementary to Probe 1 and at least one copy
of the sequence complementary to Probe 2 (double-positive droplets). The
observed pattern is relatively well balanced and dot clouds are well separated,
suggesting (i) the absence of significant bias in the amplification of the two regions
targeted by the two considered probes (exon1/exon2, and exon2/exon3) and (ii)
the applicability of the BIORAD proprietary auto-analysis tool for target
quantification. (B) Number of droplets generated in the Digital Droplet PCR
experiments. Results for eight dromedary skeletal muscles, each from two different
animals (biological replicate), analyzed in duplicate (technical replicate) are shown.
TABLE S1 | Sequence accession numbers (left panel) and links to the webpages
of databases and softwares (right panel) considered in this study.
DATA SHEET S1 | Amino acidic sequences of the 83 non redundant myostatin
proteins used for building the maximum likelihood tree presented in Figure 3. The
data are in the “multiple sequence alignment” format.
DATA SHEET S2 | Sequence of the Camelus dromedarius contig-8645394.
Exons (highlighted in yellow), 5’ and 3’ UTR regions (underlined), SNPs (highlighted
in red), the GAT codon for the aspartic acid essential for BMP/tolloid protease
cleavage (highlighted in green), and the 12 nucleotides coding for the RSRR motif
(highlighted in gray), needed for recognition by furin convertase, are shown.
DATA SHEET S3 | Results of the TFBIND analysis for the SNPs present in the C.
dromedarius myostatin gene upstream region (8 kb). AC, transcription factor
matrix code. ID, transcription factor label, with V meaning “vertebrate”. SCORE,
similarity (0.0–1.0) between a registered sequence for the transcription factor
binding sites and the input sequence. STRAND, strandness. + and − means
forward and reverse strands that the transcription factor binds, respectively.
CONSENSUS, consensus sequence (fixed) of the transcription factor binding
sites. S = C or G, W = A or T, R = A or G, Y = C or T, K = G or T, M = A or C,
N = any base pair. SIGNAL, sub-sequence from the input sequence at the position
corresponding to the consensus sequence. Default cut-offs by Tsunoda and
Takagi, 1999 were adopted. The analysis was performed, for each SNP, using the
two input sequences harboring the alternative alleles.
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